Percepta Genomic Sequencing Classifier and decision-making in patients with high-risk lung nodules: a decision impact study.

Saved in:
Bibliographic Details
Title: Percepta Genomic Sequencing Classifier and decision-making in patients with high-risk lung nodules: a decision impact study.
Authors: Sethi S; Division of Pulmonary Medicine, Respiratory Institute, Cleveland Clinic, 9500 Euclid Avenue, Mail Code A90, Cleveland, OH, 44195, USA. sethis@ccf.org., Oh S; Division of Pulmonary, Critical Care and Sleep Medicine, University of California, Los Angeles, Los Angeles, CA, USA., Chen A; Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine, St. Louis, MO, USA., Bellinger C; Pulmonary, Critical Care, Allergy and Immunologic Disease, Wake Forest School of Medicine, Winston-Salem, NC, USA., Lofaro L; Veracyte, Inc., South San Francisco, CA, USA., Johnson M; Veracyte, Inc., South San Francisco, CA, USA., Huang J; Veracyte, Inc., South San Francisco, CA, USA., Bhorade SM; Veracyte, Inc., South San Francisco, CA, USA., Bulman W; Veracyte, Inc., South San Francisco, CA, USA., Kennedy GC; Veracyte, Inc., South San Francisco, CA, USA.
Source: BMC pulmonary medicine [BMC Pulm Med] 2022 Jan 06; Vol. 22 (1), pp. 26. Date of Electronic Publication: 2022 Jan 06.
Publication Type: Journal Article
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100968563 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2466 (Electronic) Linking ISSN: 14712466 NLM ISO Abbreviation: BMC Pulm Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1471-2466
DOI:10.1186/s12890-021-01772-4